ATRIUMEDICAL

Active

Private limited companyfounded 20197 yrs activeJubelfeestlaan 36, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0733.964.455

ATRIUMEDICAL has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €58k and a net result of €25k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 11% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Watch Print / PDF

Checked score

Score 2024

68 / 100

Healthy

The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability75▼-2

Solvency36▲+5

Growth78=

Track record100

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €3.5k at 30 days acceptable

Liquidity short (current ratio 0.59 against 0.5 in 2023; short-term debt: 16.8% and cash: 9.9% of total assets), and 89.1% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Sector 86

lower

← fewer bankruptcies more bankruptcies →

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2024

Solvency, return and age of the figures

Solvency

10.9%

Return on assets

4.6%

Age of the figures

21 mo

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 19907 sector peers (2024).

NBB · sector comparison

Position among 19907 sector peers

Solvency

better than 11%

← weakest strongest →

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 5 filings

Deviation from the deadline

2025

not confirmed

2024

28 d late

2023

30 d late

2022

25 d late

2021

31 d late

2020

31 d late

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity

€58k▲ 73.5%

2023 · €34k

2020: €-160 2021: €-5k 2022: €-3k 2023: €34k

2020 → 2024

Total assets

€533k▼ 7.9%

2023 · €579k

2020: €520k 2021: €609k 2022: €570k 2023: €579k

2020 → 2024

Net result

€25k▼ 32.1%

2023 · €36k

2020: €-70k 2021: €-5k 2022: €2k 2023: €36k

2020 → 2024

Working capital

€-36k▲ 38.8%

2023 · €-59k

2020: €-51k 2021: €-99k 2022: €-91k 2023: €-59k

2020 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20202021202220232024Trend

Equity€-160-€-5k▼ 2,976%€-3k▲ 43.5%€34k€58k▲ 73.5%

Operating result€-60k-€-859▲ 98.6%€9k€42k▲ 392%€30k▼ 29.1%

Net result€-70k-€-5k▲ 93.2%€2k€36k▲ 1,598%€25k▼ 32.1%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result falls in 2024; 2024 is 29% below 2023.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €533k

90.0%

10%

Fixed assets €480k▼ 7.6%

Current assets €53k▼ 10.8%

Equity and liabilities €533k

11%

89.1%

Equity €58k▲ 73.5%

Debt €475k▼ 12.9%

The debt ratio falls from 94.2% to 89.1%. Equity is higher and debt is lower.

Key figures and ratios

2024 value · change against 2023

EBITDA

€82k▼

2023 · €92k

Cash flow

€76k▼

2023 · €86k

Solvency

10.9%▲

2023 · 5.8%

Current ratio

0.59▲

2023 · 0.50

Quick ratio

0.59▲

2023 · 0.50

Debt / equity

8.16▼

2023 · 16.26

ROE

42.4%▼

2023 · 108.3%

ROA

4.6%▼

2023 · 6.3%

Interest coverage

15.03▼

2023 · 15.30

Debt

€475k▼

2023 · €545k

Debt ≤ 1 year

€90k▼

2023 · €119k

Debt > 1 year

€385k▼

2023 · €426k

Staff costs

€85k▲

2023 · €70k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€579k€533k▼

Fixed assets21/28€519k€480k▼

Intangible fixed assets21€5k€4k▼

Tangible fixed assets22/27€514k€475k▼

Land and buildings22€507k€461k▼

Plant, machinery and equipment23€2k€8k▲

Furniture and vehicles24€4k€7k▲

Current assets29/58€60k€53k▼

Amounts receivable within one year40/41€10k€548▼

Trade receivables40€9k-

Other amounts receivable41€516€548▲

Cash at bank and in hand54/58€48k€53k▲

Deferred charges and accrued income490/1€1k€43▼

Equity and liabilities

Total equity and liabilities10/49€579k€533k▼

Equity10/15€34k€58k▲

Contributions10/11€70k€70k=

Profit (loss) carried forward14€-36k€-12k▲

Amounts payable17/49€545k€475k▼

Amounts payable after more than one year17€426k€385k▼

Financial debts170/4€426k€385k▼

Amounts payable within one year42/48€119k€90k▼

Current portion of amounts payable after more than one year42€40k€41k▲

Trade debts44€12k€3k▼

Suppliers440/4€12k€3k▼

Advances received on contracts in progress46-€1k

Taxes, remuneration and social security45€11k€14k▲

Remuneration and social security454/9€11k€14k▲

Other amounts payable47/48€56k€31k▼

Income statement Code20232024

Remuneration, social security and pensions62€70k€85k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€49k€52k▲

Other operating charges640/8€4k€5k▲

Gross operating margin9900€166k€171k▲

Operating profit (loss)9901€42k€30k▼

Financial income75/76B-€93

Recurring financial income75-€93

Financial charges65/66B€6k€5k▼

Recurring financial charges65€6k€5k▼

Profit (loss) for the period before taxes9903€36k€25k▼

Profit (loss) for the period9904€36k€25k▼

Profit (loss) for the period to be appropriated9905€36k€25k▼

Appropriation of the result

Profit (loss) to be appropriated9906€-36k€-12k▲

Profit (loss) brought forward from the previous period14P€-73k€-36k▲

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 7Financial 2Filings 5

2025

28-08

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 28 days late

2024

30-08

NBB filing Annual accounts filed

fiscal year 2023 · micro schema · 30 days late

2023

31-12

Financial Highest result since 2020net €36k ▲1598%

Operating result €42k, net result €36k, both a record.

25-08

NBB filing Annual accounts filed

fiscal year 2022 · micro schema · 25 days late

2022

31-12

Financial Back to profitnet €2k

Net result €2k after 2 loss-making years.

31-08

NBB filing Annual accounts filed

fiscal year 2021 · micro schema · 31 days late

2021

31-08

NBB filing Annual accounts filed

fiscal year 2020 · micro schema · 31 days late

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2019

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Jubelfeestlaan 361080 Sint-Jans-Molenbeek

Ground area

100 m²

Building footprint

102 m²

Volume, LiDAR

1,146 m³

Parcel 21012A0078/00S016, Brussels · tallest building 18.4 m, ±4 floors. Linked by address, not a title deed.

1 establishment unit

ATRIUMEDICAL

Jubelfeestlaan 36, 1080 Sint-Jans-MolenbeekGeneral medical practice

since 20192.294.669.018

1 parcel

Brussels 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21012A0078/00S016	Brussels	100 m²	1 · 102 m²	18.4 m · 4 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Dr. Arne Schatteman

BE 1004.189.629

Gent · Eq €58k

Docteur Ingrid Mathieu

Chaudfontaine · Eq €58k

Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,761 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded12-09-2019

Fiscal year end31-12

Activities, NACEBEL

86210General medical practice

Sources

Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.